Downregulation of Androgen, Estrogen and Progesterone Receptor Genes and Protein Is Involved in Aging-Related Erectile Dysfunction

Total Page:16

File Type:pdf, Size:1020Kb

Downregulation of Androgen, Estrogen and Progesterone Receptor Genes and Protein Is Involved in Aging-Related Erectile Dysfunction International Journal of Impotence Research (2003) 15, 391–396 & 2003 Nature Publishing Group All rights reserved 0955-9930/03 $25.00 www.nature.com/ijir Downregulation of androgen, estrogen and progesterone receptor genes and protein is involved in aging-related erectile dysfunction M Shirai1, M Yamanaka1, H Shiina1, M Igawa2, M Fujime3, TF Lue4 and R Dahiya1* 1VA Medical Center and UCSF, Urology, San Francisco, California USA; 2Shimane Medical University, Izumo, Shimane, Japan; 3Juntendo University, Bunkyo-ku, Tokyo, Japan; and 4UCSF/Mt. Zion Medical Center, Department of Urology, San Francisco, California, USA We hypothesize that downregulation of sex hormone receptors (androgen, estrogen and progesterone receptors) is involved in aging-related erectile dysfunction. To test this hypothesis, we investigated the expression of sex hormone receptors in penile crura of aging rats. A total of 40 rats were divided into four groups based on age (6, 12, 18 and 24 months), and the erectile function was analyzed by the measurement of intracavernous pressure. Gene and protein expressions of sex hormone receptors were analyzed by RT-PCR and immunostaining, respectively. The mean intracavernous pressures of 6-, 12-, 18- and 24-month-old rats were 110.1, 89.6, 73.5 and 42.7 cmH2O, respectively. Gene and protein expressions for androgen receptor, estrogen receptor- beta and progesterone receptor were present in similar levels in 6-, 12- and 18-month-old rat crura, but significantly lower or absent in 24-month-old crura. This is the first study to demonstrate that downregulation of sex hormone receptors in aging rat crura is associated with erectile dysfunction. International Journal of Impotence Research (2003) 15, 391–396. doi:10.1038/sj.ijir.3901050 Keywords: steroid hormone receptor genes; erectile dysfunction; aging Introduction and progesterone are present in the circulation in men, and it may be possible that the altered balance between sex hormones and their receptors exerts an Erectile dysfunction (ED) is common in elderly influence on male sexual function. In the central 1,2 men. The Massachusetts Male Aging Study nervous system, progesterone could mediate male reported that the combined prevalence of minimal, sexual behavior by interacting with progesterone moderate and complete ED reached up to 52% in receptor (PR) located in the olfactory bulb.4 aging men. The prevalence of complete ED tripled Although male organs produce estrogens and pro- 1 from 5 to 15% in subjects aged 40–70 y old. Older gesterone, their effects on penis are not clear. In a men are more frequently affected by systemic previous study, we have demonstrated that the diseases and often take a lot of medication. estrogen receptor-beta (ER-b) gene expression was Although it might be possible that these factors are significantly reduced in diabetic rat penis as inter-related with the higher incidence of ED, the compared to controls.5 However, there have been aging process itself undoubtedly plays a significant few reports on the relationship of sex hormone role in the development of ED. receptors (SHR) with aging-related ED. We hypothe- Circulating androgen in serum is considered to be size that SHR (androgen receptor (AR), ER and PR) one of the principal factors that affect male sexual play a significant role in maintaining the male function. It has been shown in rats that an adequate sexual function and altered levels of SHR expression testosterone level is essential to maintain the are involved in the etiology of aging-related ED. To availability of nitric oxide in the cavernous test this hypothesis, we analyzed gene and protein compartment through stimulation of expression expressions of SHR in aging rat crura and correlated and activity of penile endothelial and neuronal them with erectile function. nitric oxide synthase (NOS) isoforms.3 Estrogens Materials and methods *Correspondence: R Dahiya, VA Medical Center and UCSF, Urology, 112F, 4150 Clement Street, San Francisco, Experimental animals CA 94121, USA. E-mail: [email protected] Received 26 October 2002; revised 7 March 2003; accepted A total of 40 male Fisher rats, divided into four 11 March 2003 groups (n ¼ 10) based on age (6, 12, 18 and 24 Downregulation of sex hormone receptor genes M Shirai et al 392 months) were used in this study. These rats Louis, MO, USA) and PCR reaction buffer provided were purchased from the National Institute of by the manufacturer. The primers used for rat AR, Aging, Washington, D.C. and/or Simonson, Gilroy, ER-a, ER-b, PR and glyceraldehyde 3-phosphate California. dehydrogenase (G3PDH) as a reference gene in RT-PCR were as follows: AR forward, 50-TGTTATC TAGTCTCAACGAGC-30; AR reverse, 50-CATCATTT CAGGAAAGTCC-30; ER-a forward, 50-GTCCAATTC Electrostimulation TGACAATCG-30; ER-a reverse, 50-CTTCAACATTC TCCCTCC-30; ER-b forward, 50-TGTACCATAGACA AGAACC-3; ER-b reverse, 50-GGAGTATCTCTGTGT After anesthetizing by intraperitoneal injection of 0 0 pentobarbital (40 mg/kg), a lower abdominal inci- GAAG-3 ; PR forward, 5 -CTCCTGGATGAGCCTGA TG-30; PR reverse, 50-CCCGAATATAGCTTGACCTC- sion was made and the cavernous nerve was 0 0 0 exposed. Electrostimulation was performed using a 3 , G3PDH forward, 5 -TCCCATCACCATCTTCCA-3 and G3PDH reverse, 50-CATCACGCCACAGTTTCC- delicate stainless-steel bipolar hook electrode. The 0 diameter of each pole was 0.2 mm and the two poles 3 . PCR reactions were performed in a PTC-200 were separated by 1-mm distance. Monophasic thermal cycler (MJ Research, Watertown, MA, USA) rectangular voltage pulses were generated by a at 941C for 3 min; 32 cycles at 941C for 1 min, 521C computer and converted to current pulses by a for 1 min, 721C for 1 min; followed by final extension computer-assisted stimulator. The stimulus para- at 721C for 5 min. For semiquantitative analysis, meters were 1.5 mA, 20 Hz frequency, pulse width three other dilution sets of each sample (original, 1/ 0.2 ms and duration 60 s. Each cavernous nerve was 2, 1/4 and 1/8 dilution) underwent PCR. Annealing stimulated. For monitoring intracavernous pressure temperature was 521C for all RT-PCR reactions. The (ICP), the skin overlying the penis was incised and PCR products were electrophoresed on 2.0% agarose the penile crura were exposed. A 25-gauge needle gel and the expression level of these genes was filled with heparin solution (1000 U/ml) was inserted evaluated by an ImageJ software (http://rsb.info. into the right crus and connected to a pressure nih.gov/ij), and the areas under the curves were monitor with polyethylene tubing.6 ICP was mea- calculated and analyzed. PCR cycles were adjusted sured and recorded using a computer with Lab View until these four preparations in each sample were 5.01 software (National Instruments, Austin, TX, within linear range. Between 28 and 32 cycles all USA). The ICP was defined as the maximum SHR PCR reactions were within linear range. The pressure obtained by the stimulation minus the expression of each gene was quantified relative to basal pressure before the stimulation. G3PDH expression and expressed as arbitrary units (AU). The expected sizes of PCR products were 587 base pair (bp), 346, 633, 293 and 380 bp in AR, ER-a, ER-b, PR and G3PDH, respectively. Tissue preparation Penile crura of each rat were collected immediately Immunohistochemistry after completing electrostimulation. Half of the sample was fixed in 10% buffered formalin (pH Tissue sections were cut (4 mm) and mounted on 7.0) and embedded in paraffin wax, and used for a slide. Tissue block sections were dewaxed, immunostaining. The remaining half of each sample rehydrated, incubated with 0.3%(v/v) hydrogen 1 was immediately frozen and stored at –80 C until peroxide for 20 min, and autoclaved at 1211C for analyzed. 15 min in 10 mM citrate buffer (pH 6.0). The samples were incubated with serum block (Santa Cruz Bio- technology, Inc., Santa Cruz, CA, USA) for 20 min at Reverse transcription-polymerase chain reaction room temperature followed by overnight at 41C with (RT-PCR) the following antibodies: 1:150 dilution of a mono- clonal antibody against mouse ER-a (Ab-10) (Lab Vision Corp., Fremont, CA, USA), 1:400 dilution of a Total RNA was extracted from the samples of penile polyclonal antibody against rabbit AR (C-19), 1:400 crura using Tri-Reagent (Molecular Research Center, dilution of a polyclonal antibody against rabbit ER-b Cincinnati, OH, USA). Complementary DNA (cDNA) (H-150) and 1:100 dilution of a polyclonal antibody was constructed by reverse transcription (Promega against rabbit PR (H-190) (Santa Cruz Biotechnology, Corp., Madison, WI, USA) using the total RNA as a Inc.). After the slides were washed, they were template. The samples then underwent PCR ampli- incubated with a biotinylated goat anti-mouse anti- fication, cDNA samples were diluted in 20 mlof body and streptavidin-peroxidase (Lab Vision Corp.) solution containing 200 mM of dNTP, 500 nM of each for ER-a; or biotinylated goat anti-rabbit antibody primer, 0.5 U of Red Taq DNA polymerase (Sigma, St and HRP-streptavidin (Santa Cruz Biotechnology, International Journal of Impotence Research Downregulation of sex hormone receptor genes M Shirai et al 393 Inc.) for AR, ER-b and PR at room temperature for Gene expression of AR, ER-a, ER-b and PR in aging 30 min. Following incubation with the avidin–biotin rat crura (Figures 1 and 2). complex, the antigen–antibody complexes were visualized with diaminobenzidine (Lab Vision Corp.). The sections were counterstained using Typical results and summarized data of each RT- hematoxylin. As a negative control, normal goat PCR are shown in Figures 1 and 2, respectively. IgG was substituted for the specific antibody at There was no significant difference in AR mRNA the same dilution.
Recommended publications
  • RUNX1 Control of Mammary Epithelial and Breast Cancer Cell Phenotypes
    University of Massachusetts Medical School eScholarship@UMMS GSBS Dissertations and Theses Graduate School of Biomedical Sciences 2017-12-12 RUNX1 Control of Mammary Epithelial and Breast Cancer Cell Phenotypes Deli Hong University of Massachusetts Medical School Let us know how access to this document benefits ou.y Follow this and additional works at: https://escholarship.umassmed.edu/gsbs_diss Part of the Cancer Biology Commons, and the Cell Biology Commons Repository Citation Hong D. (2017). RUNX1 Control of Mammary Epithelial and Breast Cancer Cell Phenotypes. GSBS Dissertations and Theses. https://doi.org/10.13028/M21Q2F. Retrieved from https://escholarship.umassmed.edu/gsbs_diss/949 This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in GSBS Dissertations and Theses by an authorized administrator of eScholarship@UMMS. For more information, please contact [email protected]. RUNX1 CONTROL OF MAMMARY EPITHELIAL AND BREAST CANCER CELL PHENOTYPES A Dissertation Presented By Deli Hong Submitted to the Faculty of the University of Massachusetts Graduate School of Biomedical Sciences, Worcester in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY December 12, 2017 Program of Cell Biology RUNX1 CONTROL OF MAMMARY EPITHELIAL AND BREAST CANCER CELL PHENOTYPES A Dissertation Presented By Deli Hong This work was undertaken in the Graduate School of Biomedical Sciences Program of Cell Biology The signature of the Thesis Advisor signifies validation of Dissertation content Gary S. Stein, Ph. D., Thesis Advisor The signatures of the Dissertation Defense Committee signify completion and approval as to style and content of the Dissertation Leslie Shaw, Ph.
    [Show full text]
  • Analysis of Estrogen Receptor Isoforms and Variants in Breast Cancer Cell Lines
    EXPERIMENTAL AND THERAPEUTIC MeDICINE 2: 537-544, 2011 Analysis of estrogen receptor isoforms and variants in breast cancer cell lines MAIE AL-BADER1, CHRISTOPHER FORD2, BUSHRA AL-AYADHY3 and ISSAM FRANCIS3 Departments of 1Physiology, 2Surgery, and 3Pathology, Faculty of Medicine, Kuwait University, Safat 13110, Kuwait Received November 22, 2010; Accepted February 14, 2011 DOI: 10.3892/etm.2011.226 Abstract. In the present study, the expression of estrogen domain C, the DNA binding domain; domains D/E, bearing receptor (ER)α and ERβ isoforms in ER-positive (MCF7, both the activation function-2 (AF-2) and the ligand binding T-47D and ZR-75-1) and ER-negative (MDA-MB-231, SK-BR-3, domains; and finally, domain F, the C-terminal domain (6,7). MDA-MB-453 and HCC1954) breast cancer cell lines was The actions of estrogens are mediated by binding to ERs investigated. ERα mRNA was expressed in ER-positive and (ERα and/or ERβ). These receptors, which are co-expressed some ER-negative cell lines. ERα ∆3, ∆5 and ∆7 spliced in a number of tissues, form functional homodimers or variants were present in MCF7 and T-47D cells; ERα ∆5 heterodimers. When bound to estrogens as homodimers, the and ∆7 spliced variants were detected in ZR-75-1 cells. transcription of target genes is activated (8,9), while as heterodi- MDA-MB-231 and HCC1954 cells expressed ERα ∆5 and ∆7 mers, ERβ exhibits an inhibitory action on ERα-mediated gene spliced variants. The ERβ1 variant was expressed in all of the expression and, in many instances, opposes the actions of ERα cell lines and the ERβ2 variant in all of the ER-positive and (7,9).
    [Show full text]
  • GATA3 As an Adjunct Prognostic Factor in Breast Cancer Patients with Less Aggressive Disease: a Study with a Review of the Literature
    diagnostics Article GATA3 as an Adjunct Prognostic Factor in Breast Cancer Patients with Less Aggressive Disease: A Study with a Review of the Literature Patrizia Querzoli 1, Massimo Pedriali 1 , Rosa Rinaldi 2 , Paola Secchiero 3, Paolo Giorgi Rossi 4 and Elisabetta Kuhn 5,6,* 1 Section of Anatomic Pathology, Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, 44124 Ferrara, Italy; [email protected] (P.Q.); [email protected] (M.P.) 2 Section of Anatomic Pathology, ASST Mantova, Ospedale Carlo Poma, 46100 Mantova, Italy; [email protected] 3 Surgery and Experimental Medicine and Interdepartmental Center of Technology of Advanced Therapies (LTTA), Department of Morphology, University of Ferrara, 44121 Ferrara, Italy; [email protected] 4 Epidemiology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, 42122 Reggio Emilia, Italy; [email protected] 5 Division of Pathology, Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, 20122 Milano, Italy 6 Department of Biomedical, Surgical, and Dental Sciences, University of Milan, 20122 Milano, Italy * Correspondence: [email protected]; Tel.: +39-02-5032-0564; Fax: +39-02-5503-2860 Abstract: Background: GATA binding protein 3 (GATA3) expression is positively correlated with Citation: Querzoli, P.; Pedriali, M.; estrogen receptor (ER) expression, but its prognostic value as an independent factor remains unclear. Rinaldi, R.; Secchiero, P.; Rossi, P.G.; Thus, we undertook the current study to evaluate the expression of GATA3 and its prognostic value Kuhn, E. GATA3 as an Adjunct in a large series of breast carcinomas (BCs) with long-term follow-up. Methods: A total of 702 Prognostic Factor in Breast Cancer consecutive primary invasive BCs resected between 1989 and 1993 in our institution were arranged Patients with Less Aggressive in tissue microarrays, immunostained for ER, progesterone receptor (PR), ki-67, HER2, p53, and Disease: A Study with a Review of GATA3, and scored.
    [Show full text]
  • Expression of Aromatase, Estrogen Receptor and , Androgen
    0031-3998/06/6006-0740 PEDIATRIC RESEARCH Vol. 60, No. 6, 2006 Copyright © 2006 International Pediatric Research Foundation, Inc. Printed in U.S.A. Expression of Aromatase, Estrogen Receptor ␣ and ␤, Androgen Receptor, and Cytochrome P-450scc in the Human Early Prepubertal Testis ESPERANZA B. BERENSZTEIN, MARI´A SONIA BAQUEDANO, CANDELA R. GONZALEZ, NORA I. SARACO, JORGE RODRIGUEZ, ROBERTO PONZIO, MARCO A. RIVAROLA, AND ALICIA BELGOROSKY Research Laboratory [E.B.B., M.S.B., C.R.G., N.I.S., J.R., M.A.R., A.B.], Hospital de Pediatria Garrahan, Buenos Aires C124 5AAM, Argentina; Centro de Investigaciones en Reproduccion [R.P.], Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires C112 1ABG, Argentina ABSTRACT: The expression of aromatase, estrogen receptor ␣ might affect adult testicular cell mass, as well as testicular (ER␣) and ␤ (ER␤), androgen receptor (AR), and cytochrome P-450 function (8). side chain cleavage enzyme (cP450scc) was studied in prepubertal In humans (9), there are three growth phases of LCs testis. Samples were divided in three age groups (GRs): GR1, during testicular development. Fetal LCs produce testoster- ϭ newborns (1- to 21-d-old neonates, n 5); GR2, postnatal activation one required for fetal masculinization and Insl-3, necessary ϭ stage (1- to 7-mo-old infants, n 6); GR3, childhood (12- to for testicular descent (10). They regress during the third ϭ ␣ 60-mo-old boys, n 4). Absent or very poor detection of ER by trimester of pregnancy. A second wave of infantile LCs has immunohistochemistry in all cells and by mRNA expression was been described during the postnatal surge of luteinizing observed.
    [Show full text]
  • Expression of Estrogen Receptor-Beta Isoforms in Barrett's
    ANTICANCER RESEARCH 24: 2919-2924 (2004) Expression of Estrogen Receptor-Beta Isoforms in Barrett’s Metaplasia, Dysplasia and Esophageal Adenocarcinoma LIANG LIU, MINNI CHIRALA and MAMOUN YOUNES Departments of Pathology, Baylor College of Medicine and The Methodist Hospital, Houston, TX 77030, U.S.A. Abstract. We have previously shown that the majority of and beta (ER-B). ER-A is mainly expressed in female sex esophageal adenocarcinomas (EA), and its precursor Barrett’s organs, such as breast and uterus (2), whereas ER-B is metaplasia (BM), express estrogen receptor beta (ER-B). Several expressed in both sex organs and other tissues, such as isoforms of ER-B have been described and are presumed to have prostate, lung, thyroid, adrenal cortex and testis (3). Several different functions, but their distribution in BM and EA is not ER-B isoforms have been identified and characterized in known. The aim of this work was to determine which ER-B many non-gynecologic tumors including carcinomas of the isoforms are expressed in EA and BM. Sections of formalin-fixed lung (4), prostate (5), colon (6, 7) and stomach (8). and paraffin-embedded esophageal tissue from 33 esophageactomy Tamoxifen, a specific ER-B antagonist, has been successfully specimens, of which 27 had invasive EA, were stained for the ER- used in the treatment of patients with breast carcinoma B isoforms ER-B1, ER-B2, ER-B3 and ER-B5 utilizing the (9,10) and it has been shown that ER-B status is a significant immunoperoxidase method. ER-B1 was detected in 23 out of 27 predictor of survival in women with breast carcinoma treated (85%) EA compared to 3 out of 14 (21%) Barrett’s metaplasia with mastectomy and adjuvant tamoxifen (11).
    [Show full text]
  • I LITERATURE-BASED DISCOVERY of KNOWN and POTENTIAL NEW
    LITERATURE-BASED DISCOVERY OF KNOWN AND POTENTIAL NEW MECHANISMS FOR RELATING THE STATUS OF CHOLESTEROL TO THE PROGRESSION OF BREAST CANCER BY YU WANG THESIS Submitted in partial fulfillment of the requirements for the degree of Master of Science in Bioinformatics with a concentration in Library and Information Science in the Graduate College of the University of Illinois at Urbana-Champaign, 2019 Urbana, Illinois Adviser: Professor Vetle I. Torvik Professor Erik Russell Nelson i ABSTRACT Breast cancer has been studied for a long period of time and from a variety of perspectives in order to understand its pathogeny. The pathogeny of breast cancer can be classified into two groups: hereditary and spontaneous. Although cancer in general is considered a genetic disease, spontaneous factors are responsible for most of the pathogeny of breast cancer. In other words, breast cancer is more likely to be caused and deteriorated by the dysfunction of a physical molecule than be caused by germline mutation directly. Interestingly, cholesterol, as one of those molecules, has been discovered to correlate with breast cancer risk. However, the mechanisms of how cholesterol helps breast cancer progression are not thoroughly understood. As a result, this study aims to study known and discover potential new mechanisms regarding to the correlation of cholesterol and breast cancer progression using literature review and literature-based discovery. The known mechanisms are further classified into four groups: cholesterol membrane content, transport of cholesterol, cholesterol metabolites, and other. The potential mechanisms, which are intended to provide potential new treatments, have been identified and checked for feasibility by an expert.
    [Show full text]
  • Influence of Androgen Receptor on the Prognosis of Breast Cancer
    Journal of Clinical Medicine Article Influence of Androgen Receptor on the Prognosis of Breast Cancer 1, , 2, 1 2 3 Ki-Tae Hwang * y , Young A Kim y , Jongjin Kim , Jeong Hwan Park , In Sil Choi , Kyu Ri Hwang 4 , Young Jun Chai 1 and Jin Hyun Park 3 1 Department of Surgery, Seoul Metropolitan Government Seoul National University Boramae Medical Center, 39, Boramae-Gil, Dongjak-gu, Seoul 156-707, Korea; [email protected] (J.K.); [email protected] (Y.J.C.) 2 Department of Pathology, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul 156-707, Korea; [email protected] (Y.A.K.); [email protected] (J.H.P.) 3 Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul 156-707, Korea; [email protected] (I.S.C.); [email protected] (J.H.P.) 4 Department of Obstetrics & Gynecology, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul 156-707, Korea; [email protected] * Correspondence: [email protected]; Tel.: +82-2-870-2275; Fax: +82-2-831-2826 These authors contributed equally to this work. y Received: 28 February 2020; Accepted: 8 April 2020; Published: 10 April 2020 Abstract: We investigated the prognostic influence of androgen receptor (AR) on breast cancer. AR status was assessed using immunohistochemistry with tissue microarrays from 395 operable primary breast cancer patients who received curative surgery. The Kaplan–Meier estimator was used to analyze the survival rates and a log-rank test was used to determine the significance of the differences in survival. The Cox proportional hazards model was used to calculate the hazard ratio (HR) and the 95% confidence interval (CI) of survival.
    [Show full text]
  • Homeobox Gene Expression Profile in Human Hematopoietic Multipotent
    Leukemia (2003) 17, 1157–1163 & 2003 Nature Publishing Group All rights reserved 0887-6924/03 $25.00 www.nature.com/leu Homeobox gene expression profile in human hematopoietic multipotent stem cells and T-cell progenitors: implications for human T-cell development T Taghon1, K Thys1, M De Smedt1, F Weerkamp2, FJT Staal2, J Plum1 and G Leclercq1 1Department of Clinical Chemistry, Microbiology and Immunology, Ghent University Hospital, Ghent, Belgium; and 2Department of Immunology, Erasmus Medical Center, Rotterdam, The Netherlands Class I homeobox (HOX) genes comprise a large family of implicated in this transformation proces.14 The HOX-C locus transcription factors that have been implicated in normal and has been primarily implicated in lymphomas.15 malignant hematopoiesis. However, data on their expression or function during T-cell development is limited. Using degener- Hematopoietic cells are derived from stem cells that reside in ated RT-PCR and Affymetrix microarray analysis, we analyzed fetal liver (FL) in the embryo and in the adult bone marrow the expression pattern of this gene family in human multipotent (ABM), which have the unique ability to self-renew and thereby stem cells from fetal liver (FL) and adult bone marrow (ABM), provide a life-long supply of blood cells. T lymphocytes are a and in T-cell progenitors from child thymus. We show that FL specific type of hematopoietic cells that play a major role in the and ABM stem cells are similar in terms of HOX gene immune system. They develop through a well-defined order of expression, but significant differences were observed between differentiation steps in the thymus.16 Several transcription these two cell types and child thymocytes.
    [Show full text]
  • Immunohistochemical Study of Androgen, Estrogen and Progesterone Receptors in Salivary Gland Tumors
    Oral Pathology Oral Pathology Immunohistochemical study of androgen, estrogen and progesterone receptors in salivary gland tumors Fabio Augusto Ito(a) Abstract: The aim of this work was to study the immunohistochemi- (b) Kazuhiro Ito cal expression of androgen receptor, estrogen receptor and progesterone Ricardo Della Coletta(c) Pablo Agustín Vargas(c) receptor in pleomorphic adenomas, Warthin’s tumors, mucoepidermoid Márcio Ajudarte Lopes(c) carcinomas and adenoid cystic carcinomas of salivary glands. A total of 41 pleomorphic adenomas, 30 Warthin’s tumors, 30 mucoepidermoid carcinomas and 30 adenoid cystic carcinomas were analyzed, and the im- (a) DDS, PhD; (b)MD, Professor – Department of Pathology, Londrina State University, munohistochemical expression of these hormone receptors were assessed. Londrina, PR, Brazil. It was observed that all cases were negative for estrogen and progesterone (c) DDS, PhD, Professor, Department of Oral receptors. Androgen receptor was positive in 2 cases each of pleomorphic Diagnosis, Piracicaba Dental School, University of Campinas (UNICAMP), adenoma, mucoepidermoid carcinoma and adenoid cystic carcinoma. In Piracicaba, SP, Brazil. conclusion, the results do not support a role of estrogen and progesterone in the tumorigenesis of pleomorphic adenomas, Warthin’s tumors, muco- epidermoid carcinomas and adenoid cystic carcinomas. However, andro- gen receptors can play a role in a small set of salivary gland tumors, and this would deserve further studies. Descriptors: Receptors, androgen; Receptors, estrogen; Receptors, progesterone; Salivary gland neoplasms. Corresponding author: Márcio Ajudarte Lopes Semiologia, Faculdade de Odontologia de Piracicaba, UNICAMP Av. Limeira, 901 Caixa Postal: 52 CEP: 13414-903 Piracicaba - SP - Brazil E-mail: [email protected] Received for publication on Oct 01, 2008 Accepted for publication on Sep 22, 2009 Braz Oral Res.
    [Show full text]
  • Progesterone Receptor Isoform B Regulates the Oxtr-Plcl2-Trpc3 Pathway to Suppress Uterine Contractility
    Progesterone receptor isoform B regulates the Oxtr-Plcl2-Trpc3 pathway to suppress uterine contractility Mary C. Peaveya,1, San-Pin Wub,1, Rong Lib, Jian Liub, Olivia M. Emeryb, Tianyuan Wangc, Lecong Zhouc, Margeaux Wetendorfd, Chandra Yallampallie, William E. Gibbonse, John P. Lydond, and Francesco J. DeMayob,2 aDepartment of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, NC 27599; bReproductive and Developmental Biology Laboratory, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709; cIntegrative Bioinformatic Support Group, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709; dDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030; and eDepartment of Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX 77030 Edited by R. Michael Roberts, University of Missouri, Columbia, MO, and approved January 19, 2021 (received for review June 6, 2020) Uterine contractile dysfunction leads to pregnancy complications The “progesterone receptor isoform switch” concept was posited such as preterm birth and labor dystocia. In humans, it is hypoth- to explain the transition from a quiescent to a contractile myometrial esized that progesterone receptor isoform PGR-B promotes a re- phenotype in the presence of high levels of progesterone (10, 11, laxed state of the myometrium, and PGR-A facilitates uterine 26–30). Progesterone acts via the nuclear receptor isoforms, PGR-A contraction. This hypothesis was tested in vivo using transgenic and PGR-B, which are coexpressed at different levels throughout mouse models that overexpress PGR-A or PGR-B in smooth muscle pregnancy (31–35). Progesterone can transactivate different tran- cells. Elevated PGR-B abundance results in a marked increase in scriptional programs determined by the relative levels of PGR-A and gestational length compared to control mice (21.1 versus 19.1 d PGR-B isoforms in the myometrium (36–41).
    [Show full text]
  • The Novel Progesterone Receptor
    0013-7227/99/$03.00/0 Vol. 140, No. 3 Endocrinology Printed in U.S.A. Copyright © 1999 by The Endocrine Society The Novel Progesterone Receptor Antagonists RTI 3021– 012 and RTI 3021–022 Exhibit Complex Glucocorticoid Receptor Antagonist Activities: Implications for the Development of Dissociated Antiprogestins* B. L. WAGNER†, G. POLLIO, P. GIANGRANDE‡, J. C. WEBSTER, M. BRESLIN, D. E. MAIS, C. E. COOK, W. V. VEDECKIS, J. A. CIDLOWSKI, AND D. P. MCDONNELL Department of Pharmacology and Cancer Biology (B.L.W., G.P., P.G., D.P.M.), Duke University Medical Center, Durham, North Carolina 27710; Molecular Endocrinology Group (J.C.W., J.A.C.), NIEHS, National Institutes of Health, Research Triangle Park, North Carolina 27709; Department of Biochemistry and Molecular Biology (M.B., W.V.V.), Louisiana State University Medical School, New Orleans, Louisiana 70112; Ligand Pharmaceuticals, Inc. (D.E.M.), San Diego, California 92121; Research Triangle Institute (C.E.C.), Chemistry and Life Sciences, Research Triangle Park, North Carolina 27709 ABSTRACT by agonists for DNA response elements within target gene promoters. We have identified two novel compounds (RTI 3021–012 and RTI Accordingly, we observed that RU486, RTI 3021–012, and RTI 3021– 3021–022) that demonstrate similar affinities for human progeste- 022, when assayed for PR antagonist activity, accomplished both of rone receptor (PR) and display equivalent antiprogestenic activity. As these steps. Thus, all three compounds are “active antagonists” of PR with most antiprogestins, such as RU486, RTI 3021–012, and RTI function. When assayed on GR, however, RU486 alone functioned as 3021–022 also bind to the glucocorticoid receptor (GR) with high an active antagonist.
    [Show full text]
  • Biomedicines
    biomedicines Article The Fabp4-Cre-Model is Insufficient to Study Hoxc9 Function in Adipose Tissue Sebastian Dommel 1,*, Claudia Berger 1 , Anne Kunath 1, Matthias Kern 1, Martin Gericke 2,3, Peter Kovacs 1 , Esther Guiu-Jurado 1, Nora Klöting 1,4 and Matthias Blüher 1,4,* 1 Medical Department III—Endocrinology, Nephrology, Rheumatology, University of Leipzig Medical Center, D-04103 Leipzig, Germany; [email protected] (C.B.); [email protected] (A.K.); [email protected] (M.K.); [email protected] (P.K.); [email protected] (E.G.-J.); [email protected] (N.K.) 2 Institute of Anatomy, Leipzig University, D-04103 Leipzig, Germany; [email protected] 3 Institute of Anatomy and Cell Biology, Martin-Luther-University, D-06108 Halle (Saale), Germany 4 Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Zentrum München at the University of Leipzig and University Hospital Leipzig, Leipzig University, D-04103 Leipzig, Germany * Correspondence: [email protected] (S.D.); [email protected] (M.B.); Tel.: +49-341-9713400 (S.D.); +49-341-9715984 (M.B.) Received: 18 May 2020; Accepted: 26 June 2020; Published: 29 June 2020 Abstract: Developmental genes are important regulators of fat distribution and adipose tissue (AT) function. In humans, the expression of homeobox c9 (HOXC9) is significantly higher in subcutaneous compared to omental AT and correlates with body fat mass. To gain more mechanistic insights into the role of Hoxc9 in AT, we generated Fabp4-Cre-mediated Hoxc9 knockout mice (ATHoxc9-/-).
    [Show full text]